Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene - PubMed (original) (raw)

Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene

T Iwamoto et al. EMBO J. 1991 Nov.

Abstract

We generated four independent transgenic mouse lines that showed severe melanosis of the whole body by introducing the ret oncogene fused to the mouse metallothionein (MT)-I promoter-enhancer (MT/ret). Whereas melanogenesis was accelerated without distinct proliferative disorders in one line, melanocytic tumours frequently developed in the other three lines. Northern hybridization and in situ hybridization analyses showed that tumour cells and non-tumorous melanin-producing cells expressed the transgene at high levels. The aberrant melanogenesis and tumour development were influenced by genetic and environmental factors. Furthermore, crossbreeding experiments between the transgenic mice and Wv mice suggested that the ret gene product can partially compensate for the defect of melanocyte development in Wv mice. This is a novel mammalian model in which melanosis and melanocytic tumours develop stepwise, triggered by a single transgene.

PubMed Disclaimer

Similar articles

• The ret oncogene can induce melanogenesis and melanocyte development in Wv/Wv mice.
  Iwamoto T, Takahashi M, Ohbayashi M, Nakashima I. Iwamoto T, et al. Exp Cell Res. 1992 Jun;200(2):410-5. doi: 10.1016/0014-4827(92)90189-f. Exp Cell Res. 1992. PMID: 1374037
• Proliferation and neoplastic transformation of pigment cells in metallothionein/ret transgenic mice.
  Takahashi M, Iwamoto T, Nakashima I. Takahashi M, et al. Pigment Cell Res. 1992 Nov;5(5 Pt 2):344-7. doi: 10.1111/j.1600-0749.1992.tb00560.x. Pigment Cell Res. 1992. PMID: 1292018 Review.
• Linkage between melanocytic tumor development and early burst of Ret protein expression for tolerance induction in metallothionein-I/ret transgenic mouse lines.
  Kato M, Liu W, Akhand AA, Dai Y, Ohbayashi M, Tuzuki T, Suzuki H, Isobe K, Takahashi M, Nakashima I. Kato M, et al. Oncogene. 1999 Jan 21;18(3):837-42. doi: 10.1038/sj.onc.1202329. Oncogene. 1999. PMID: 9989837
• Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene.
  Iwamoto T, Taniguchi M, Wajjwalku W, Nakashima I, Takahashi M. Iwamoto T, et al. Br J Cancer. 1993 Mar;67(3):504-7. doi: 10.1038/bjc.1993.94. Br J Cancer. 1993. PMID: 8439501 Free PMC article.
• [Melanocyte, melanogenesis and the adjustment of melanogenesis].
  Pan XH, Chen ZL, Huang LN. Pan XH, et al. Sheng Li Ke Xue Jin Zhan. 1998 Apr;29(2):179-81. Sheng Li Ke Xue Jin Zhan. 1998. PMID: 12501694 Review. Chinese. No abstract available.

Cited by

• Mapping of melanoma modifier loci in RET transgenic mice.
  Dragani TA, Peissel B, Zanesi N, Aloisi A, Dai Y, Kato M, Suzuki H, Nakashima I. Dragani TA, et al. Jpn J Cancer Res. 2000 Nov;91(11):1142-7. doi: 10.1111/j.1349-7006.2000.tb00897.x. Jpn J Cancer Res. 2000. PMID: 11092979 Free PMC article.
• Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours.
  Santoro M, Sabino N, Ishizaka Y, Ushijima T, Carlomagno F, Cerrato A, Grieco M, Battaglia C, Martelli ML, Paulin C, et al. Santoro M, et al. Br J Cancer. 1993 Sep;68(3):460-4. doi: 10.1038/bjc.1993.370. Br J Cancer. 1993. PMID: 8353035 Free PMC article.
• Tumor Cell-Derived Angiopoietin-2 Promotes Metastasis in Melanoma.
  Abdul Pari AA, Singhal M, Hübers C, Mogler C, Schieb B, Gampp A, Gengenbacher N, Reynolds LE, Terhardt D, Géraud C, Utikal J, Thomas M, Goerdt S, Hodivala-Dilke KM, Augustin HG, Felcht M. Abdul Pari AA, et al. Cancer Res. 2020 Jun 15;80(12):2586-2598. doi: 10.1158/0008-5472.CAN-19-2660. Epub 2020 Apr 17. Cancer Res. 2020. PMID: 32303578 Free PMC article.
• Reduced GNG2 expression levels in mouse malignant melanomas and human melanoma cell lines.
  Yajima I, Kumasaka MY, Naito Y, Yoshikawa T, Takahashi H, Funasaka Y, Suzuki T, Kato M. Yajima I, et al. Am J Cancer Res. 2012;2(3):322-9. Epub 2012 Apr 21. Am J Cancer Res. 2012. PMID: 22679562 Free PMC article.
• Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice.
  El Khoury D, Destouches D, Lengagne R, Krust B, Hamma-Kourbali Y, Garcette M, Niro S, Kato M, Briand JP, Courty J, Hovanessian AG, Prévost-Blondel A. El Khoury D, et al. BMC Cancer. 2010 Jun 24;10:325. doi: 10.1186/1471-2407-10-325. BMC Cancer. 2010. PMID: 20573279 Free PMC article.

References

1. 1. Oncogene. 1989 Jun;4(6):805-6 - PubMed
2. 1. Oncogene. 1990 Sep;5(9):1291-6 - PubMed
3. 1. J Cell Biol. 1989 Dec;109(6 Pt 1):3115-28 - PubMed
4. 1. Anal Biochem. 1987 Apr;162(1):156-9 - PubMed
5. 1. EMBO J. 1987 Dec 20;6(13):4055-65 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • PubMed Central
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)